Tag: research
-
Pioneering new cancer vaccine planned in England
The government have signed an agreement with German pharmaceutical company BioNTech to ensure their innovative vaccine research comes to England.
-
Childhood medulloblastoma origin uncovered, opening new doors for treatment
Researchers have found the origin of group 3 and 4 childhood medulloblastoma, which could help develop new treatments for children diagnosed with one of the most common forms of cancerous brain tumour.
-
Ulixertinib may change childhood brain tumour treatment
New research suggests that ulixertinib may offer one of the first targeted therapies for the most common form of brain tumour in children.
-
Trial finds DCVax-L may prolong the lives of those living with a glioblastoma
A major phase III clinical trial has found that novel treatment DCVax®-L may prolong the lives of people diagnosed with a new or recurrent glioblastoma.
-
World-leading expert appointed as The Brain Tumour Charity neuro-oncology chair at University of Manchester
We are delighted to announce the appointment of the first-ever The Brain Tumour Charity Chair of Translational Neuro-Oncology at The University of Manchester’s Cancer Research Centre (MCRC).
-
Navigating the path unknown –James’ story.
James was first diagnosed with a brain tumour after having a seizure in 2018. Since then, he has had two awake craniotomies and a string of treatment types. Here, he shares his story on how he has navigated the uncertainty which came with it all.
-
Interview with co-founder of Black in Cancer, Sigourney Bell – part two.
The second part of our interview with Sigourney Bell, a third-year PHD candidate at the CRUK Cambridge Institute and co-Founder of Black in Cancer.
-
Interview with co-founder of Black in Cancer, Sigourney Bell – part one.
We spoke with Sigourney Bell, a third-year PHD candidate at the CRUK Cambridge Institute and co-Founder of Black in Cancer, about her experiences as a researcher.
-
‘Noah’s Ark’ language test could help diagnose brain tumours earlier
Verbal fluency test to name animals found to identify those with persistent headaches who are more likely to have a brain tumour, and could help GPs decide who needs rapid imaging.
-
Why getting involved in clinical research is important to me!
In this blog, Stephen tells us why it is so important to take part in clinical research. He talks us through his experience of volunteering in the Sativex clinical trial (Phase 1) and joining the Involvement Network.
-
We respond to “promising” survival data from phase III trial of DCVax®-L
We respond to preliminary overall survival data from phase III clinical trial that suggests DCVax-L may help extend survival for patients with newly-diagnosed or recurrent glioblastomas.
-
Looking to our Future Leaders
New Year, new research grant opportunities as The Charity is returning to traditional research funding after the pandemic pause with our substantial Future Leaders grants.
-
Major UK trial to assess whether cannabis-based drug could extend life for thousands with aggressive brain tumours
A major UK trial of cannabis-based drug Sativex in treating the most aggressive form of brain tumour is to launch at 15 NHS hospitals, following promising results from a phase I study in 27 patients.
-
A genetic mutation causing DMG and a potential drug to treat it
Geneticists from Trinity College Dublin have discovered how a specific genetic mutation called H3K27M causes a devastating, incurable childhood cancer, known as diffuse midline glioma (DMG), and, in lab studies working with model cell types, successfully reverse its effects to slow cancer cell growth with a targeted drug.
-
Telomeres- a cancer cell’s fountain of youth
If we can find a way to interrupt a cancer cell’s ability to keep dividing, we may have a key to stopping tumours growing. Researchers, Dr Wong and Dr Voon ,tells us about the discovery they made into a tumour’s ability to continuously divide.
-
Molecular profiles show up clinical trial benefits
Research we funded has added value to a clinical trial that started in 2004. Updated scientific techniques showed that some children with a medulloblastoma can safely be spared harmful treatments.
-
Brain tumour AI helping others
Artificial intelligence (AI) may be the key to fast and consistent renal cell tumour diagnoses, all because of work we fund on brain tumours.
-
The impact a gift can make
Back in 2015 we launched our five year strategy ‘Defeating Brain Tumours’ and our research strategy ‘A Cure Can’t Wait’. Our manifestos were unashamedly ambitious, but we knew they had to be.
-
Shining a light on the differences between glioblastoma cells
A new publication from one of our research projects shines a light on the differences between the cells in the middle/core of a glioblastoma (GBM) compared to the cells spreading/infiltrating into healthy brain around the tumour.
-
Picking up the pace of meningioma research
Dr Gelareh Zadeh is leading research in Canada which will help predict the risk of meningioma regrowth.
-
The advances of AI in healthcare
In April, NHSX, the unit whose remit is to deliver the digital transformation of the health service, will begin running a new artificial intelligence (AI) Lab.
-
New Less Survivable Cancers Taskforce report released today
Brain tumours among diseases that miss out on research funding, says our joint charity report
-
Your vote for innovation
For a limited time the voting is open to decide the semifinalists in our Brain Race, with the Centre for Advancing Innovation. Which discoveries do you want to see go forward?
-
Meet Dr Martina Finetti
Dr Martina Finetti tells us about her background and her research into rare childhood brain tumours.